SUSQUEHANNA INTERNATIONAL GROUP, LLP - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$269,993,505
+2.8%
2,333,767
-8.6%
0.06%
+3.7%
Q2 2023$262,647,531
+137.7%
2,553,695
+152.2%
0.05%
+134.8%
Q1 2023$110,510,144
-50.7%
1,012,554
-48.6%
0.02%
-59.6%
Q4 2022$224,238,917
+378.1%
1,970,465
+160.0%
0.06%
+375.0%
Q3 2022$46,904,000
-11.2%
757,879
+14.4%
0.01%
-7.7%
Q2 2022$52,839,000
-10.3%
662,471
+18.4%
0.01%
+30.0%
Q1 2022$58,884,000
-42.5%
559,674
-41.1%
0.01%
+233.3%
Q4 2021$102,474,000
+8.3%
950,934
+10.1%
0.00%
-76.9%
Q3 2021$94,602,000
+14.1%
863,636
-2.4%
0.01%
+8.3%
Q2 2021$82,881,000
-5.7%
885,105
-7.3%
0.01%
-14.3%
Q1 2021$87,880,000
-39.9%
954,801
-52.3%
0.01%
+27.3%
Q4 2020$146,338,000
+242.3%
2,000,512
+263.5%
0.01%
+37.5%
Q3 2020$42,751,000
+87.5%
550,345
+34.2%
0.01%
+60.0%
Q2 2020$22,795,000
+82.1%
410,127
-2.9%
0.01%
+66.7%
Q1 2020$12,515,000
-53.9%
422,503
-43.7%
0.00%
-62.5%
Q4 2019$27,175,000
+143.1%
750,692
+82.8%
0.01%
+100.0%
Q3 2019$11,180,000
-7.7%
410,587
-18.4%
0.00%
+300.0%
Q2 2019$12,107,000503,2040.00%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q2 2022
NameSharesValueWeighting ↓
Kopp Family Office, LLC 544,835$57,322,00030.98%
Paulson & Co. 5,614,000$590,649,00018.18%
Avoro Capital Advisors LLC 6,500,000$683,865,00012.48%
1492 Capital Management LLC 121,840$12,819,0006.80%
Iron Triangle Partners LP 503,744$52,999,0006.30%
Tri Locum Partners LP 132,332$13,923,0005.44%
HealthCor Management, L.P. 710,110$74,711,0004.98%
Eversept Partners, LP 609,939$64,171,6824.93%
Bain Capital Public Equity Management II, LLC 1,286,371$135,339,0004.33%
PFM Health Sciences, LP 1,091,840$114,872,0004.30%
View complete list of HORIZON THERAPEUTICS PUB L shareholders